News

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.
A health expert has weighed in the debate around so-called ‘Ozempic feet’ as people claim side effect is spotted on celebs ...
Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...
Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...
Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...
Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for ...
At its peak, WeightWatchers was seen as being synonymous with safe and controlled weight loss. With 4.5million subscribers ...
Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...
We expected miracles; what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...
Ozempic, Wegovy and Mounjaro can still be expensive, but pharmacy-produced GLP-1 compounds are becoming much more affordable.
A doctor has issued an warning as to why Ozempic shouldn't be used for weight loss as it does one alarming thing to body.
As we learn more about GLP-1 drugs like Wegovy and Zepbound, early research suggests that they may be able to improve COPD ...